首页> 外国专利> Methods and compositions for the use of a Vaccine against coccidiosis, preparation of multivalent Vaccine, vector, Cell isolation

Methods and compositions for the use of a Vaccine against coccidiosis, preparation of multivalent Vaccine, vector, Cell isolation

机译:用于抗球虫病的疫苗的方法和组合物,多价疫苗的制备,载体,细胞分离

摘要

Claim 1: a vaccine to protect Poultry coccidiosis Eimeria Infections, characterized in that it comprises a vaccine recombinant Avian adenovirus vector, which comprises a promoter operably linked to a Hydrophobic Signal sequence, which includes a Nucleic Acid encoding a Membrane Anchor domain.A multiple cloning site for insertion of a open reading frame (ORF), with which it is possible to insert an ORF in the same framework with The Hydrophobic Signal sequence, a polyadenylation signal and a Genome of Avian adenovirus.Claim 2: Vaccine against coccidiosis of claim 1, wherein the ORF encodes an Antigen of interest selected from the group consisting of a truncated R56 Antigen of Eimeria maxima, a tfp250 truncated Antigen of Eimeria maxima and 82 kDa Antigen of TRUNC Ado of Eimeria maxima.Claim 5: Vaccine against coccidiosis of claim 1, wherein Said Avian adenovirus Genome is a Genome of Fav 8.Claim 6: Vaccine against coccidiosis of claim 1, wherein Said recombinant Avian adenovirus vector also comprises a Cutting Sequence immediately towards the 5 'end of the cloning site for insertion of the ORF of interest, where the produc To the expression of the Vector is a soluble product.Claim 7: Vaccine against coccidiosis of claim 1, wherein Said Nucleic Acid encodes an Antigen selected from the group consisting of: (a) a truncated R56 Antigen that includes the sequence of nucleotides 70 - 1035 of the complete sequence of R56, Q EU shown in seq. Id.HL: 13, but does not Encode the Protein Sequence complete R56, shown in seq. ID no: 2; (b) an Antigen R56 truncated fragment encoding the truncated R56, consists of 24 amino acids - 345 of seq. ID no: 2, or a 24 amino acid fragment - 345 of seq. Id.HL: 2; (c) a tfp250 truncated Antigen that includes the sequence of 6448 - 7083 nucleotides of the complete sequence of tfp250, shown in seq. Id: 16 NS, but does not Encode the Protein sequence tfp250 thorough, illustrated in seq. ID no: 4; and (d) an antigen tfp250 is truncated in the Nucleic Acid Sequence comprising 6448 - 7083 nucleotides of seq. Id.HL: 16.Claim 24: a recombinant Avian adenovirus vector characterized in that it comprises a promoter operably linked to a Hydrophobic Signal Sequence comprising a Nucleic Acid encoding a Membrane Anchor Domain, a multiple cloning site for insertion of d And an ORF of interestIt is possible to insert an ORF of interest in the same framework with The Hydrophobic Signal sequence, a polyadenylation signal and a Genome of Avian adenovirus. Claim: a 40 isolated Cell which comprises the recombinant Avian adenovirus vector of claim 24.
机译:权利要求1:一种保护家禽球虫艾美球虫感染的疫苗,其特征在于它包含疫苗重组禽腺病毒载体,该载体包含与疏水信号序列可操纵地连接的启动子,该启动子包括编码膜锚结构域的核酸。权利要求1的抗球虫病疫苗:开放阅读框(ORF)的插入位点,可以将其与疏水信号序列,聚腺苷酸化信号和禽腺病毒基因组插入同一框架中。 5.根据权利要求1所述的抗球虫病疫苗,其特征在于,所述ORF编码选自最大艾美球虫的R56抗原,最大艾美尔球虫的tfp250截短的抗原和最大艾美尔球虫TRUNC Ado的82kDa抗原的目标抗原。 8.根据权利要求1所述的抗球虫病的疫苗,其中所述禽腺病毒基因组是Fav 8的基因组。6.根据权利要求1所述的抗球虫病的疫苗,其中所述重组禽腺病毒载体7.根据权利要求1所述的抗球虫病的疫苗,其中,所述核仁在紧接克隆位点5'端处具有用于插入目的ORF的切割序列,其中所表达的载体是可溶产物。酸编码选自以下的抗原:(a)截短的R56抗原,包括R56完整序列Q EU的核苷酸70-1035的序列,如以下所示。编号HL:13,但不编码完整的蛋白质序列R56,如以下序列所示。身份证号码:2; (b)编码R56截短的抗原R56截短的片段,由24个氨基酸-345个seq组成。 ID号:2,或24个氨基酸的片段-345个序列。编号HL:2; (c)tfp250截短的抗原,其包含tfp250完整序列的6448至7083个核苷酸的序列,如以下序列所示。 Id:16 NS,但未完整编码蛋白质序列tfp250,如以下序列所示。身份证号码:4; (d)抗原tfp250在核酸序列中被截短,该核酸序列包含SEQ ID NO:1的6448-7083个核苷酸。 Id.HL:16。权利要求24:一种重组禽腺病毒载体,其特征在于它包含与疏水信号序列可操作地连接的启动子,该疏水信号序列包含编​​码膜锚结构域的核酸,用于插入d的多克隆位点和ORF的ORF。感兴趣的可能在与疏水信号序列,聚腺苷酸化信号和禽腺病毒基因组相同的框架中插入感兴趣的ORF。 40.分离的细胞,其包含权利要求24的重组禽腺病毒载体。

著录项

  • 公开/公告号AR074679A1

    专利类型

  • 公开/公告日2011-02-02

    原文格式PDF

  • 申请/专利权人 VECTOGEN PTY LTD.;

    申请/专利号AR2009P104894

  • 发明设计人 SHEPPARD MICHAEL G.;

    申请日2009-12-15

  • 分类号A61K39/00;A61K39/012;A61K39/235;C12N15/861;C12N7/01;A61P33/02;

  • 国家 AR

  • 入库时间 2022-08-21 18:07:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号